BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 15676220)

  • 21. Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Dickmeiss E; Vindeløv LL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):48-60. PubMed ID: 16399568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A; Salooja N; Russell-Jones R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
    Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.
    Fowler DH; Odom J; Steinberg SM; Chow CK; Foley J; Kogan Y; Hou J; Gea-Banacloche J; Sportes C; Pavletic S; Leitman S; Read EJ; Carter C; Kolstad A; Fox R; Beatty GL; Vonderheide RH; Levine BL; June CH; Gress RE; Bishop MR
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1150-60. PubMed ID: 17085308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
    Meng XJ; Lin MF; Cai Z
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease.
    Tanaka J; Imamura M; Kasai M; Hashino S; Kobayashi S; Noto S; Higa T; Sakurada K; Asaka M
    Bone Marrow Transplant; 1997 Mar; 19(6):571-6. PubMed ID: 9085737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Ritchie D; Seconi J; Wood C; Walton J; Watt V
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):706-12. PubMed ID: 16125641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
    Remberger M; Ringden O; Markling L
    Bone Marrow Transplant; 1995 Jan; 15(1):99-104. PubMed ID: 7742764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
    Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S
    Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune reconstitution following allogeneic peripheral blood stem cell transplants.
    Shenoy S; Mohanakumar T; Todd G; Westhoff W; Dunnigan K; Adkins DR; Brown RA; DiPersio JF
    Bone Marrow Transplant; 1999 Feb; 23(4):335-46. PubMed ID: 10100577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Hildebrandt GC; Choi SW; Mueller G; Olkiewicz KM; Moore BB; Cooke KR
    Pediatr Blood Cancer; 2008 Apr; 50(4):911-4. PubMed ID: 17455319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function.
    Nawa Y; Teshima T; Sunami K; Hiramatsu Y; Maeda Y; Yano T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 2000 May; 25(10):1035-40. PubMed ID: 10828862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
    Nagler A; Bishara A; Brautbar C; Barak V
    Cytokines Cell Mol Ther; 1998 Sep; 4(3):161-7. PubMed ID: 9825841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.